Researchers screened more than 1,000 intensive care unit patients for S. aureus upon admission over a 14-month period, recording the genotype of each strain. Of the nearly 200 patients who tested positive for S. aureus, only 18.7 percent had an infection contracted from another patient. The source of the remaining infections remains untraced.
The study concluded more work must be done to identify the source of hospital-acquired S. aureus infections, as the low percentage of patient-to-patient transmission means infection control efforts must be refocused for maximum effectiveness.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
